Biphasic interactions between a cationic dendrimer and actin

Journal of Drug Targeting

Volumn 18, Issue 10, 2010, Pages 803-811

  Ruenraroengsak, Pakatip ^a,b   Florence, Alexander T ^a  

^a UNIVERSITY OF LONDON   (United Kingdom)

^b NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

Actin; Actin polymerization; Dendrimer interaction; Dendrimers

Indexed keywords

ACTIN; ANTINEOPLASTIC AGENT; CATIONIC DENDRIMER; DENDRIMER; UNCLASSIFIED DRUG;

ACTIN FILAMENT; ACTIN POLYMERIZATION; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG PROTEIN BINDING; DRUG TRANSPORT; IN VITRO STUDY; IN VIVO STUDY; MOLECULAR INTERACTION; NONHUMAN; PRIORITY JOURNAL; STATIC ELECTRICITY;

ACTINS; ANIMALS; BIOLOGICAL TRANSPORT; CATIONS; CYTOPLASM; DENDRIMERS; GENE TRANSFER TECHNIQUES; NANOPARTICLES; POLYMERIZATION; RABBITS; STATIC ELECTRICITY;

EID: 78149448666     PISSN: 1061186X     EISSN: 10292330     Source Type: Journal    
DOI: 10.3109/1061186X.2010.521159     Document Type: Article

References (34)

1. Al-Jamal KT, Ruenraroengsak P, Hartell N, Florence AT. 2006. An intrinsically fluorescent dendrimer as a nanoprobe of cell transport. J Drug Target 14:405-412.
2. Alberts B, Johnson A, Lewis L, Raff M, Roberts K, Water P. 2002. The cytoskeleton and cell junction. In: The Cell (Anderson MS, Dilernia B, Eds.), 4th ed. Taylor & Francis, New York.
3. Bakshi MS, Kaura A. 2005. Fluorescence studies of interactions of ionic surfactants with poly(amidoamine) dendrimers. J Colloid Interface Sci 284:680-686.
4. Carraway KL, Carraway CAC. 1992. The Cytoskeleton: A Practical Approach. Oxford University Press, Oxford. Chen CZ, Cooper SL. 2002. Interactions between dendrimer biocides and bacterial membranes. Biomaterials 23:3359-3368.
5. Chiba T, Yoshimura T, Esumi K. 2003. Physicochemical properties of aqueous mixed solutions of sugar-persubstituted poly(amidoamine) dendrimers and bovine serum albumin. Colloids Surf A 214:157-165.
6. Cooper JA, Buhle EL, Jr, Walker SB, Tsong TY, Pollard TD. 1983. Kinetic evidence for a monomer activation step in actin polymerization. Biochemistry 22:2193-2202.
7. Duan X, McLaughlin C, Griffith M, Sheardown H. 2007. Biofunctionalization of collagen for improved biological response: scaffolds for corneal tissue engineering. Biomaterials 28:78-88.
8. Duan X, Sheardown H. 2006. Dendrimer crosslinked collagen as a corneal tissue engineering scaffold: mechanical properties and corneal epithelial cell interactions. Biomaterials 27:4608-4617.
9. Fernandez J, Geiger B, Salomon D, Sabanay I, Zoller M, Zeev A. 1992. Suppression of tumorigenicity in transformed cells after transfection with Vinculin cDNA. J Cell Biol 119:427-438.
10. Frieden C. 1983. Polymerization of actin: mechanism of the Mg2+- induced process at pH 8 and 20 OC. Proc Natl Acad Sci USA 80:6513-6517.
11. Holme TC. 1990. Cancer cell structure: actin changes in tumour cells-possible mechanisms for malignant tumour formation. Eur J Surg Onc 16:161-169.
12. Kao HP, Abney JR, Verkman AS. 1993. Determinants of the translational mobility of a small solute in cell cytoplasm. J Cell Biol 120:175-184.
13. Klajnert B, Cortijo-Arellano M, Cladera J, Bryszewska M. 2006b. Influence of dendrimers structure on its activity against amyloid fibril formation. Biochem Biophy Res Comm 345:21-28.
14. Klajnert B, Janiszewska J, Urbanczyk-Lipkowska Z, Bryszewska M, Epand RM. 2006a. DSC studies on interactions between low molecular mass peptide dendrimers and model lipid membranes. Int J Pharm 327:145-152.
15. Klajnert B, Sadowska M, Bryszewska M. 2004. The effect of polyamidoamine dendrimers on human erythrocyte membrane acetylcholinesterase activity. Bioelectrochemistry 65:23-26.
16. Klajnert B, Stanislawska L, Bryszewska M, Palecz B. 2003. Interactions between PAMAM dendrimers and bovine serum albumin. Biochim Biophys Acta 1648:115-126.
17. Laemmli UK. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-688.
18. Lal AA, Korn ED. 1985. Reinvestigation of the inhibition of actin polymerization by profilin. J Biol Chem 260:10132-10138.
19. Menjoge AR, Kannan RM, Tomalia DA. 2010. Dendrimer based drug and imaging conjugates: design considerations for nanomedical applications. Drug Discov Today 15:171-185.
20. Milhem OM, Myles C, McKeown NB, Attwood D, DEmanuele A. 2000. Polyamidoamine Starburst(R) dendrimers as solubility enhancers. Int J Pharm 197:239-241.
21. Pan B-F, Gao F, Ao L-M. 2005. Investigation of interactions between dendrimer-coated magnetite nanoparticles and bovine serum albumin. J Magnet Magnet Mater 293:252-258.
22. Pitkä;nen L, Ruponen M, Nieminen J, Urtti A. 2003. Vitreous is a barrier in nonviral gene transfer by cationic lipids and polymers. Pharm Res 20:576-583.
23. Prasad G, Fuldner R, Cooper H. 1993. Expression of transduced tropomyosin 1 cDNA suppresses neoplastic growth of cells transformed by the ras oncogene. Proc Natl Acad Sci USA 90:7039-7043.
24. Purohit G, Sakthivel T, Florence AT. 2003. The interaction of cationic dendrons with albumin and their diffusion through cellulose membranes. Int J Pharm 254:37-41.
25. Roiz L, Smirnoff P, Bar-Eli M, Schwartz B, Shoseyov O. 2006. ACTIBIND, an actin-binding fungal T2-RNase with antiangiogenic and anticarcinogenic characteristics. Am Can Soc 106:2295-2308.
26. Ruenraroengsak P, Al-Jamal KT, Hartell N, Braeckmans K, De Smedt SC, Florence AT. 2007. Cell uptake, cytoplasmic diffusion and nuclear access of a 6.5 nm diameter dendrimer. Int J Pharm 331:215-219.
27. Ruenraroengsak P, Cook JM, Florence AT. 2010. Nanosystem drug targeting: facing up to complex realities. J Control Release 141:265-276.
28. Ruponen M, Honkakoski P, Ronkko S, Pelkonen J, Tammi M, Urtti A. 2003. Extracellular and intracellular barriers in non-viral gene delivery. J Control Release 93:213-217.
29. Ruponen M, Yla-Herttuala S, Urtti A. 1999. Interactions of polymeric and liposomal gene delivery systems with extracellular glycosaminoglycans: physicochemical and transfection studies. Biochim Biophys Acta 1415:331-341.
30. Tanaka M, Mullauer L, Ogiso Y. 1995. Gelsolin: a candidate for suppressor of human bladder cancer. Cancer Res 55:3228-3232.
31. Tobacman LS, Korn ED. 1983. The kinetics of actin nucleation and polymerization. J Biol Chem 258:3207-3214.
32. Tomalia DA. 2009. In quest of a systematic framework for unifying and defining nanoscience. J Nanoparticle Res 11:1251-1310.
33. Tomalia DA. 2010. Dendrons/dendrimers: quantized, nano-element like building blocks for soft-soft and soft-hard nanocompound synthesis. Soft Matter 6:456-474.
34. Wegner A, Savko P. 1982. Fragmentation of actin filaments. Biochemistry 21:1909-1913.